e-learning
resources
Madrid 2019
Monday, 30.09.2019
Biomarkers and beyond in idiopathic interstitial pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prognostic impact of radiological findings in unclassifiable interstitial lung diseases
S. Torrisi (Heidelberg, Germany), C. Hyldgaard (Aarhus, Denmark), N. Kahn (Heidelberg, Germany), C. Heussel (Heidelberg, Germany), C. Vancheri (Catania, Italy), E. Bendstrup (Aarhus, Denmark), M. Kreuter (Heidelberg, Germany)
Source:
International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Session:
Biomarkers and beyond in idiopathic interstitial pneumonia
Session type:
Poster Discussion
Number:
2247
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Torrisi (Heidelberg, Germany), C. Hyldgaard (Aarhus, Denmark), N. Kahn (Heidelberg, Germany), C. Heussel (Heidelberg, Germany), C. Vancheri (Catania, Italy), E. Bendstrup (Aarhus, Denmark), M. Kreuter (Heidelberg, Germany). Prognostic impact of radiological findings in unclassifiable interstitial lung diseases. 2247
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Prognostic validation of cryobiopsy for the diagnosis of interstitial lung diseases
Source: International Congress 2019 – Transbronchial cryobiopsy and endobronchial ultrasound
Year: 2019
Prognostic determinants in IPF patients with the histological features of usual interstitial pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 526s
Year: 2001
Unclassifiable interstitial lung disease: predictive factors of mortality and radiologic features
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019
Prognostic significance of clinical and morphological features in idiopathic interstitial pneumonias
Source: Eur Respir J 2002; 20: Suppl. 38, 61s
Year: 2002
Clinical characteristics of patients with unclassifiable interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Correlation between HRTC appearance and histopathological features in the diagnosis of interstitial lung diseases
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018
Clinical pitfalls in diagnosing interstitial lung disease
Source: International Congress 2014 – PG02 Current clinical problems in pulmonology
Year: 2014
Prognostic significance of pretreatment clinical and laboratory characteristics in patients with diffuse malignant pleural mesothelioma
Source: Eur Respir J 2006; 28: Suppl. 50, 784s
Year: 2006
Clinical characteristics of anti-Jo-1-positive interstitial lung disease
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019
Prevalence and prognosis of unclassifiable interstitial lung disease
Source: Eur Respir J 2013; 42: 750-757
Year: 2013
Prevalence and prognosis of unclassifiable interstitial lung disease
Source: Eur Respir J 2014; 43: 1529-1530
Year: 2014
Role of lung biopsies in the diagnosis of interstitial lung diseases in a clinical real-life setting
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
The analysis of prognostic factors in patients with interstitial lung diseases
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Prognostic factors of idiopathic pulmonary fibrosis diagnosed by surgical lung biopsy
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009
Analyses of predictive findings indicative of progressive interstitial lung diseases
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Clinical features and outcomes of patients with myositis associated-interstitial lung disease
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Prognostic relevance of histologic features in nonspecific interstitial pneumonia (NSIP)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Evaluate of radiological, bronchoscopical and histopathological features of patients with primary lung cancer
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008
Potential prognostic factors in typical and atypical carcinoid tumours of the lung - immunhistochemical investigations
Source: Eur Respir J 2001; 18: Suppl. 33, 229s
Year: 2001
Clinical characteristics and prognosis of fibrotic nonspecific interstitial pneumonia
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept